EcoDrugPlus

Cathepsin S-Like

Ensembl ID : ENSCGOG00000009104
Gene Symbol: LOC115015608
2 Cross references
181 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSCGOG00000015358
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCGOG00000010625
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSCGOG00000020330
Gene Symbol: LOC115026810
2 Cross references
195 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSCGOG00000000429
Gene Symbol: LOC115018950
3 Cross references
198 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSCGOG00000013608
Gene Symbol: LOC115003685
3 Cross references
259 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSCGOG00000009062
Gene Symbol: CHRM2
3 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSCGOG00000013429
Gene Symbol: CHRM3
3 Cross references
188 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSCGOG00000014811
Gene Symbol: CHRM3
3 Cross references
187 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSCGOG00000002650
Gene Symbol: CHRM4
3 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSCGOG00000017136
Gene Symbol: CHRM5
3 Cross references
190 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSCGOG00000014982
Gene Symbol: CHRNA3
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).